Forxiga - direct healthcare professional communication (DHPC)

dapagliflozin propanediol monohydrate
DHPCHuman

Bulgarian is available via eTranslation, the European Commission's machine translation service.

Translate to Bulgarian | Important information about machine translation

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Документи

Direct healthcare professional communication (DHPC): Forxiga (dapagliflozin) 5mg should no longer be used for the treatment of Type 1 Diabetes Mellitus

English (EN) (115.5 KB - PDF)

Публикувано за първи път:
Виж

Key facts

Medicine name
Forxiga
Active substance
dapagliflozin propanediol monohydrate
Therapeutic area (MeSH)
Diabetes Mellitus, Type 2
Procedure number
EMEA/H/C/002322/II/0071
Regulatory outcome
Variation
DHPC type
Type II variation
Human ATC codes
A10BK01
Dissemination date

Share this page